njliu
![]()
Posts:142
Great new video post by Dr. Riley on Treatment Options for EGFR T790M+ patients on Jan 9. It highlighted the common approach to EGFR patients: 1st/2nd Gen TKI( median duration 8-13 months), followed by 3rd Gen TKI (median duration 8-10 months) upon developing T790M resistance. I wonder if there is any observation from that pool of data to correlate first duration and the second, for example, to say that a durable response to 1st/2nd TKI would increase or decrease the likelihood of durable response to 3rd TKI.
NJ
Forums
Reply # - January 10, 2016, 03:03 PM
Hi NJ, I don't know the
Hi NJ, I don't know the answer to that and will need to have a doctor comment. For chemo the answer is responders respond.
I hope she does very well moving forward.
Janine
Reply # - January 10, 2016, 04:55 PM
Sorry, but we don't have any
Sorry, but we don't have any data yet to speak to that question. Perhaps, but data to address that question have never been presented or published.
Good luck.
-Dr. West